OMNI 360 Wealth Inc. acquired a new position in CME Group Inc. (NASDAQ:CME - Free Report) during the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund acquired 1,382 shares of the financial services provider's stock, valued at approximately $367,000.
Several other hedge funds also recently made changes to their positions in CME. Vanguard Group Inc. boosted its holdings in shares of CME Group by 1.0% during the fourth quarter. Vanguard Group Inc. now owns 34,243,090 shares of the financial services provider's stock worth $7,952,273,000 after purchasing an additional 326,623 shares during the period. Geode Capital Management LLC lifted its stake in CME Group by 1.3% in the fourth quarter. Geode Capital Management LLC now owns 8,389,442 shares of the financial services provider's stock valued at $1,946,717,000 after acquiring an additional 104,697 shares during the last quarter. Price T Rowe Associates Inc. MD lifted its stake in CME Group by 89.9% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 8,280,785 shares of the financial services provider's stock valued at $1,923,047,000 after acquiring an additional 3,921,278 shares during the last quarter. Norges Bank acquired a new stake in CME Group in the fourth quarter valued at approximately $1,107,389,000. Finally, FIL Ltd lifted its stake in CME Group by 1.5% in the fourth quarter. FIL Ltd now owns 4,081,391 shares of the financial services provider's stock valued at $947,821,000 after acquiring an additional 61,908 shares during the last quarter. Institutional investors and hedge funds own 87.75% of the company's stock.
CME Group Stock Performance
CME Group stock traded down $0.45 on Thursday, hitting $275.19. The company's stock had a trading volume of 1,589,813 shares, compared to its average volume of 2,195,936. The firm has a market cap of $99.17 billion, a P/E ratio of 27.69, a price-to-earnings-growth ratio of 3.74 and a beta of 0.44. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. The company has a fifty day moving average price of $276.73 and a 200-day moving average price of $258.73. CME Group Inc. has a one year low of $193.17 and a one year high of $290.79.
CME Group (NASDAQ:CME - Get Free Report) last announced its earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.61 by $0.19. The business had revenue of $1.64 billion during the quarter, compared to analysts' expectations of $1.56 billion. CME Group had a net margin of 57.71% and a return on equity of 14.03%. The firm's revenue for the quarter was up 10.4% on a year-over-year basis. During the same quarter last year, the company posted $2.50 EPS. On average, equities analysts anticipate that CME Group Inc. will post 10.49 earnings per share for the current year.
CME Group Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Wednesday, June 25th. Investors of record on Monday, June 9th were given a dividend of $1.25 per share. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.82%. The ex-dividend date was Monday, June 9th. CME Group's dividend payout ratio (DPR) is currently 50.30%.
Wall Street Analysts Forecast Growth
A number of equities analysts have recently commented on the stock. Citigroup lifted their price target on shares of CME Group from $265.00 to $275.00 and gave the company a "neutral" rating in a research report on Thursday, July 3rd. Keefe, Bruyette & Woods lifted their price target on shares of CME Group from $265.00 to $273.00 and gave the company a "market perform" rating in a research report on Thursday, April 24th. Barclays lifted their price target on shares of CME Group from $283.00 to $299.00 and gave the company an "equal weight" rating in a research report on Thursday. Morgan Stanley lifted their price target on shares of CME Group from $301.00 to $304.00 and gave the company an "overweight" rating in a research report on Thursday, April 24th. Finally, JPMorgan Chase & Co. dropped their price target on shares of CME Group from $223.00 to $211.00 and set an "underweight" rating on the stock in a research report on Thursday, April 24th. Three analysts have rated the stock with a sell rating, nine have given a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat.com, CME Group presently has an average rating of "Hold" and a consensus target price of $260.93.
View Our Latest Report on CME Group
Insider Buying and Selling at CME Group
In related news, Director Charles P. Carey sold 500 shares of the stock in a transaction dated Tuesday, June 10th. The shares were sold at an average price of $265.35, for a total transaction of $132,675.00. Following the completion of the sale, the director owned 4,900 shares in the company, valued at $1,300,215. This trade represents a 9.26% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, General Counsel Jonathan L. Marcus sold 390 shares of the firm's stock in a transaction dated Tuesday, May 20th. The shares were sold at an average price of $277.50, for a total transaction of $108,225.00. Following the completion of the sale, the general counsel owned 6,708 shares of the company's stock, valued at $1,861,470. The trade was a 5.49% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 13,400 shares of company stock worth $3,680,610 over the last ninety days. Company insiders own 0.30% of the company's stock.
CME Group Profile
(
Free Report)
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Recommended Stories
Before you consider CME Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.
While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
